Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 98416501000001119 | Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) 120 dose (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 98416601000001115 | Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) 120 dose | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) 120 dose | Is a | Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray 120 dose | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) 120 dose | Has AMP | Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) 120 dose | Has excipient | Excipient not declared | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) 120 dose | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) 120 dose | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) 120 dose | Has specific active ingredient | Azelastine hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) 120 dose | Has specific active ingredient | Fluticasone propionate | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) 120 dose | Has dispensed dose form | Spray dose form | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) 120 dose | Legal category | Prescription only medicine - legal category (qualifier value) | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) 120 dose | Discontinued indicator | Never discontinued | false | Inferred relationship | Existential restriction modifier | ||
| Fluticasone propionate 50micrograms/dose / Azelastine 137micrograms/dose nasal spray (Ennogen Healthcare Ltd) 120 dose | Is a | Actual medicinal product pack | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR